Logo
T

Tridek-One

10 employees

Tridek-One is a biopharmaceutical company aiming to develop immunomodulatory compounds targeting the CD31 pathway.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Santé
ANCA
Life Science
vasculatis
Healthcare
Health Care
Immunomodulation
monoclonal antibody

Date founded

2018

Funding rounds raised

Total raised

$16M

from 6 investors over 6 rounds

T

Tridek-One raised $16M on September 15, 2022

Investors: Pureos Bioventures, Bioqube Ventures, Advent Life Sciences and AdBio partners

T

Tridek-One raised $3.4M on June 4, 2019

Investors: AdBio partners and Advent Life Sciences

FAQ